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University of Santiago de Compostela, Santiago de Compostela, Spain
August 20, 2016
Abstract
Before the use of a diagnostic test in a routine clinical setting, the rigorous evalua-
tion of its diagnostic accuracy is an essential step. The receiver operating characteristic
(ROC) curve is the measure of accuracy most widely used for continuous diagnostic
tests. However, the possible impact of extra information about the patient (or even
the environment) on diagnostic accuracy needs to be also assessed. In this paper,
attention is focused on an estimator for the covariate-specific ROC curve based on
direct regression modelling and nonparametric smoothing techniques. This approach
defines the class of generalized additive models for the ROC curve (ROC-GAM). The
main aim of the paper is to offer new inferential procedures for testing the effect of co-
variates over the conditional ROC curve within the ROC-GAM context. Specifically,
two different bootstrap-based tests are suggested to check (a) the possible effect of
continuous covariates on the ROC curve; and (b) the presence of factor-by-curve in-
teraction terms. The validity of the proposed bootstrap-based procedures is supported
by simulations. To facilitate the application of these new procedures in practice, an
R-package, known as npROCRegression, is provided and briefly described. Finally, data
derived from a computed-aided diagnostic (CAD) system for the automatic detection
of tumour masses in breast cancer is analysed.
1
1 Introduction
In many biometrical applications, the classification of individuals or observations based on
covariate information is one of the most important goals of a statistical analysis. For exam-
ple, the classification of patients as healthy or diseased (to consider only the most simple
classification task) on the basis of demographic information and individual disease history
would be the point of departure for subsequent treatment. In this context, a diagnostic
test can be any diagnostic procedure conducted to differentiate between different types of
patients, e.g. healthy versus diseased or patients in different stages of disease progression.
However, classification of an individual’s status based on the result of a diagnostic test
is usually not error-free and some individuals will be misclassified. Accordingly, before
the routine application of a diagnostic test in clinical practice, any errors of classification
must be quantified in order to check a diagnostic test’s validity or invalidity, i.e. diagnostic
accuracy or ability to discriminate between alternative health states must be measured.
In the case of binary or dichotomous tests, diagnostic accuracy is often summarised
by means of the true positive fraction (TPF) and the false positive fraction (FPF). Let Y
denote the result of the diagnostic test (Y = 1 for diseased and Y = 0 for healthy), and D
the dummy variable indicating the true disease status (D = 1 for presence and D = 0 for
absence of the disease). The TPF or ‘sensitivity’ then is the probability of an individual
being correctly classified as diseased, i.e. TPF = P (Y = 1 | D = 1), whereas the FPF or
‘1−specificity’ is the probability of a healthy individual being falsely classified as diseased,
i.e. FPF = P (Y = 1 | D = 0).
For tests with continuous or ordinal results, the most widely used measure of diagnostic
accuracy is the receiver operating characteristic (ROC) curve (Krzanowski and Hand 2009,
Pepe 2003, Zhou, Obuchowski and McClish 2002). The ROC curve extends the concepts
of sensitivity and specificity to the continuous/ordinal case by depicting these quantities
for all possible cut-off values or decision thresholds c applied to the test result, i.e. it
relies on all possible transformations to a binary test. More specifically, the ROC curve is
defined as the set of all TPF-FPF pairs {(TPF (c) , FPF (c)) , c ∈ (−∞,∞)} that can be
obtained by varying the cut-off value c, where TPF (c) = P (Y ≥ c | D = 1) and FPF (c) =
P (Y ≥ c | D = 0). When the diagnostic test Y is continuous, the ROC curve is usually






for 0 ≤ p ≤ 1, where SD (c) = P (Y ≥ c | D = 1)
and SD̄ (c) = P (Y ≥ c | D = 0).
It is well known, however, that in many situations the discriminatory capacity or
accuracy of a diagnostic test can be affected by covariates (see Pepe 2003; pp 48–49,
for examples). In such cases, failure to incorporate information furnished by covariates
in the ROC analysis may lead to erroneous conclusions (Janes and Pepe 2008; 2009,
Pardo-Fernández et al. 2014). Denoting as X the d-variate vector of covariates we are
interested in, the conditional or covariate-specific ROC curve, given a covariate value x, is
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defined as




(p | x) | x
)
, 0 ≤ p ≤ 1, (1)
where, by a slight abuse of notation, SD (c | x) = P (Y ≥ c | D = 1,X = x) and
SD̄ (c | x) = P (Y ≥ c | D = 0,X = x). Note that a continuum of different ROC curves
(and, therefore, a continuum of different diagnostic accuracies) is obtained by varying the
value x in the range of X. As a consequence, the conditional ROC curve curve can be
viewed as a tool which helps identifying those patients’ strata (or subpopulations) that
may benefit from the application of the diagnostic test, as well as those for which the test
does not provide valuable information.
Estimation of the conditional ROC curve has been explored in the statistical liter-
ature from (semi) parametric and nonparametric perspectives, and within frequentist
and Bayesian paradigms. A detailed review and comparison of (semi) parametric fre-
quentist proposals can be found in Rodŕıguez-Álvarez et al. (2011c), whereas the pa-
per by Pardo-Fernández et al. (2014) mainly focuses on the nonparametric counterparts.
In brief, there are two main strategies to approach estimation: one based on estimat-
ing the conditional cumulative survival functions involved in the definition given in (1)
(Inácio de Carvalho et al. 2013, López-de-Ullibarri et al. 2008); and the other based on
modelling (and estimating) the effect of covariates on the ROC curve through regres-
sion models. In the latter case, the literature on ROC regression techniques has led to
two different methodologies: ‘induced’ and ‘direct’ (Pepe 2003). Induced methodology
is based on inducing the expression of the conditional ROC curve through regressing the
diagnostic test on the available covariates separately in healthy and diseased individu-
als (Faraggi 2003, González-Manteiga et al. 2011, Pepe 1998, Rodŕıguez and Mart́ınez
2014, Rodŕıguez-Álvarez et al. 2011a, Yao et al. 2010, Zheng and Heagerty 2004). On
the other hand, direct methodology directly regress the ROC curve. This methodology has
yielded to (1) the general class of ROC-GLM regression models (Alonzo and Pepe 2002,
Cai 2004, Cai and Pepe 2002, Pepe and Cai 2004), due to its similarity to generalized
linear models (GLM, McCullagh and Nelder 1989); and (2) its extension to a more flexible
regression setting, the ROC-GAM class (Rodŕıguez-Álvarez et al. 2011b), along the line
of the generalized additive model (GAM, Hastie and Tibshirani 1990).
The aims of this paper are twofold. Firstly, as in any regression context, in the ROC
regression framework it is important to have formal procedures for testing model assump-
tions and/or covariates’ effects. In spite of its importance, to the best of our knowledge
this topic has received little attention in the statistical literature, especially in the non-
parametric framework. Interesting contributions to the topic can be found in the paper
by Cai and Zheng (2007), where several model checking procedures for (semi) parametric
approaches are presented, and in the paper by Rodŕıguez-Álvarez et al. (2011b), where
a bootstrap-based test to check for the effect of a continuous covariate is proposed. This
paper thus focuses on presenting new inferential procedures for testing the effect of covari-
ates over the conditional ROC curve. Specifically, we present two different bootstrap-based
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tests to check (a) the possible effect of continuous covariates on the ROC curve; and (b) the
presence of factor-by-curve interaction terms. Both tests are framed within the ROC-GAM
context.
Secondly, nowadays there is an undeniable need for software developments of new statis-
tical methods. In fact, the implementation of new methodological advances in user-friendly
software has dramatically increased in the last few years. This tendency has had an im-
portant impact on shortening the time from the development of new statistical advances
to their application. Therefore, accompanying this paper we provide a free R-package
(R Core Team 2016) called, npROCRegression. The package allows for the practical appli-
cation of several nonparametric approaches to the inclusion of covariates in the ROC curve.
More precisely, npROCRegression implements the nonparametric induced and direct propos-
als as presented in Rodŕıguez-Álvarez et al. (2011a) and Rodŕıguez-Álvarez et al. (2011b)
respectively, as well as the inferential procedures described in this paper. The package is
freely available from CRAN at https://cran.r-project.org/package=npROCRegression.
We hope that the existence of easy-to-use software will encourage the use of these tech-
niques in clinical research.
The remainder of the paper is structured as follows: Section 2 briefly discusses the
statistical literature on the inclusion of covariate information in the ROC regression frame-
work. Section 3 presents in more detail the class of ROC-GAM regression models, and in
Section 4 the proposed bootstrap-based procedures are introduced. The performance of
these procedures have been evaluated by means of simulations, and results are present in
Section 5. Section 6 describes the npROCRegression R-package. We illustrate our approach
and the usage of the package in Section 7 using data from a computed-aided diagnostic
(CAD) system. The Discussion closes the paper. Some technical details are made available
in an appendix.
2 Modelling covariate effects on the ROC curve
This section reviews the literature on ROC curves in the presence of covariate information.
It is beyond the scope of this paper to present an exhaustive review, and we refer the readers
to Pepe (2003), Rodŕıguez-Álvarez et al. (2011c) and Pardo-Fernández et al. (2014) for
a more in-deep survey. However, with this section we aim at setting in a context different
modelling strategies for the incorporation of covariates on the ROC curve. More precisely,
we focus here on those that can be viewed as coming within the general framework of
regression, namely ‘induced’ and ‘direct’ methodologies. A qualitative comparison of both
approaches is also presented. The section ends up presenting several summary statistics of
the conditional ROC curve.
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2.1 ROC regression approaches
2.1.1 Induced ROC regression methodology.
This approach is based on firstly modelling the effect of covariates on the diagnostic test,
and then compounding the conditional ROC curve. In its most general specification, a
location-scale regression model is assumed for the classification variable Y in each popula-
tion separately
YD̄ = (Y | D = 0) = µD̄(X) + σD̄(X)εD̄,
YD = (Y | D = 1) = µD(X) + σD(X)εD,
where, for j ∈ {D̄,D}, µj (x) = E (Yj |X = x) and σ
2
j (x) = V ar(Yj |X = x) are the
conditional mean and the conditional variance of Yj given X = x, respectively. The
error εj is assumed independent of the covariate X, with zero mean, unit variance and
cumulative survival function Gj , i.e., Gj (c) = P (εj ≥ c). With this configuration, and













Note that, under this approach, the effect of the covariates on the ROC curve is expressed
in terms of their effects on the mean and variance of the diagnostic test in healthy and
diseased subjects.
In a parametric or semiparametric framework, important references on the estimation
of induced methodology include Pepe (1998), Faraggi (2003) and Zheng and Heagerty
(2004). All these papers propose modelling the covariate effects on the result of the di-
agnostic test parametrically. Nonparametric specifications of the conditional means and
variances have been considered in Yao et al. (2010), González-Manteiga et al. (2011),
Rodŕıguez-Álvarez et al. (2011a) and Rodŕıguez and Mart́ınez (2014). The first three pa-
pers propose fully nonparametric estimators based on kernel-type regression techniques
(Fan and Gijbels 1996). We should note that these proposals are restricted to one-
dimensional covariates. The proposal by Rodŕıguez and Mart́ınez (2014), framed in a
Bayesian setting, allows for incorporating multidimensional continuous covariates, but the
authors assume that the error terms are distributed according to a Student’s t.
2.1.2 Direct ROC regression methodology.
In contrast to induced, direct methodology directly models the effects of covariates on the
ROC curve. In this approach, the general form of the conditional ROC curve is given by
the following regression model
ROCx (p) = g (µ (x) + h0 (p)) , (2)
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where function µ collects the effects of the covariates on the ROC curve, h0 is a monoton-
ically increasing baseline function of the FPF, p (responsible for modelling the shape of
the ROC curve), and g is the function linking the covariates and FPF with the conditional
TPFs (i.e., the ROC curve).
In the (semi) parametric framework, different proposals have been suggested in the
literature, which mainly differ in the assumptions made about the function of the FPF,
h0 (·) (see Alonzo and Pepe 2002, Cai 2004, Cai and Pepe 2002, Pepe and Cai 2004). In
all these approaches the effect of covariates X on the ROC curve is incorporated paramet-
rically, i.e., µ (x) = βTx. Thus, models such as (2) define the so-called class of ROC-GLMs
(Pepe 2003), due to their resemblance to generalized linear models (GLMs). To the extent
of our knowledge, up to date, only the paper by Rodŕıguez-Álvarez et al. (2011b) addresses
the inclusion of covariate information on direct modelling nonparametrically. In that paper
the authors propose to extend the class of ROC-GLM regression models by assuming an
ROC-GAM regression model for the ROC curve. In this case, rather than assuming a
parametric form for the effect of the continuous covariates, it is solely assumed that these
effects can be represented by arbitrary smooth functions. We discuss this approach in more
detail in Section 3.
2.1.3 Qualitative comparison.
As seen, there are two different regression methodologies for the incorporation of covariates
into the ROC analysis. From an applied point of view, the natural question arising is:
which one should be used in practice?. Unfortunately, there is no simple answer. Both
methodologies present appealing features and may provide valuable information. We would
therefore suggest using both, whenever it is possible.
Regarding induced methodology, its main advantage relies on modelling covariate effects
on the result of the diagnostic test. Even though, on the one hand, it implies that the
modelling of covariate effects on the ROC curve is indirect, on the other hand (a) it
allows the use of more “standard” regression techniques and model checking procedures
than direct methodology, especially in the parametric framework; and (b) it relates the
effect of the covariates on the mean and variance of the diagnostic test to that on the
ROC curve, which can help understanding and explaining the covariate impact on the
accuracy of the test. Secondly, for ease of reading, throughout all of our presentation,
covariates affecting the test results in healthy and diseased population where assumed to
be the same while this is not necessarily the case in practice (e.g., disease stage). Induced
methodology allows incorporating specific covariates of healthy or diseased populations,
or even both. Lastly, note that by modelling covariate effects on the variance of the
diagnostic test, the shape of the ROC curve is allowed to vary with the covariates. In
regression terminology, this would be equivalent to including the interaction between the
covariates and the FPF, p. However, if the covariate vector X is multidimensional (and no
restrictions are imposed), heteroskedasticity would also imply that the interaction among
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all covariates (and possibly the FPF) is to be implicitly incorporated into de “model” for
the conditional ROC curve. This can make the interpretation and visualization of results
considerably difficult, especially in the presence of several continuous covariates. Moreover,
testing for covariate effects on the ROC curve would become a complex task.
As far as direct methodology is concerned, its obvious advantage it that it directly
evaluates covariate effect on the measure of interest, the ROC curve. As a consequence,
it enables the accuracy of different diagnostic test to be compared (Pepe 2003). In addi-
tion, inclusion of multidimensional covariates is straightforward, and interactions among
covariates can be accommodated in a more natural way than through induced methodol-
ogy. Moreover, although it has not been considered above, it is possible to incorporate the
interaction between covariates and the FPF. However, to the best of our knowledge, none
of the approaches presented in the statistical literature ensures that the resulting interac-
tion estimates are monotonic in the FPF direction as required by theoretical properties
of the ROC curve. This is undoubtedly an interesting topic of research. Finally, direct
methodology also allows incorporating disease-specific covariates. It does not, however,
permit health-related information.
2.2 Conditional summary statistics
It is common to summarize the information of the ROC curve by means of single indexes.
We list here those which are most commonly used, and present a summary measure mean-
ingful in the conditional case.
2.2.1 Area under the conditional ROC curve.
The area under the ROC curve (AUC) is possibly the most widely used summary measure




ROCx (p) dp. (3)
The AUCx ranges from 0.5 to 1, taking the value of 0.5 in the case of an uninformative
test and 1 in that of a perfect test.
The most obvious way to estimate the conditional AUC is to just plug-in an estimate for
the conditional ROC curve in (3), and approximate the integral using numerical integration
methods. However, this approach might not be the most efficient way, and several methods
to directly estimate AUCx have been proposed in the literature. For instance, Faraggi
(2003) discusses a fully parametric estimation approach based on induced modelling. In
Dodd and Pepe (2003a;b) and Cai and Dodd (2008) a semiparametric regression model
for the conditional (partial) AUC is proposed, similar in spirit to the direct ROC regression
methodology. In a fully nonparametric setting, Yao et al. (2010) present a “conditional”
Mann-Whitney estimator for AUCx estimation. This method has been recently extended
to functional covariates by Inácio de Carvalho et al. (2016).
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2.2.2 Conditional Youden index.
Another common summary index is the Youden index (Youden 1950), which in the con-
ditional case can be defined as
Y Ix = max
cx
{TPF (cx | x)− FPF (cx | x)}
= max
cx
{SD (cx | x)− SD̄ (cx | x)} (4)
= max
px
{ROCx (px)− px} , (5)
where we use the notation cx and px to emphasize that these values depend on covariate
x. The Y Ix takes values between 0.5, in the case of an uninformative test, and 1.0 in a
perfect test. The value c∗x which maximises (4) is frequently used in practice as a threshold
value to separate diseased from healthy status (in those individuals with covariate value
x).
Parametric and nonparametric approaches to the estimation of the conditional Youden
index (and associated threshold value) can be found in Faraggi (2003) and Xu et al.
(2014), among others.
2.2.3 Covariate adjusted ROC curve.
All measures discussed above depict the accuracy of a diagnostic test but for specific
covariate values. However, it would be undoubtedly interesting to have a global summary
that also takes covariate information into account. To that aim, Janes and Pepe (2009)
propose the covariate-adjusted ROC curve (AROC), defined as
AROC (p) =
∫
ROCx (p) dHD (x) , (6)
where HD (x) = P (X ≤ x | D = 1). Thus, the AROC curve is an average of conditional
ROC curves, weighted according to the distribution of the covariates in the diseased pop-
ulation. It should be noted that when a diagnostic test’s discriminatory capacity is not
affected by covariates, this does not necessarily imply that the conditional ROC curve
(which in this case is common to all covariate values) coincides with ROC curve obtained
on pooling the data regardless of the values of the covariates. It coincides, however, with
the AROC curve (see Janes and Pepe 2009, Pardo-Fernández et al. 2014; for more de-
tails). As a consequence, even in those situations where the accuracy of a test does not
vary along with the covariates, inferences based on the pooled ROC curve might be biased,
and thus meaningless. In such cases the AROC curve should be used instead.
To the best of our knowledge, estimation of the AROC curve has been only discussed
in Janes and Pepe (2009), from both (semi) parametric and nonparametric perspectives;
and in Rodŕıguez-Álvarez et al. (2011a), in the context of nonparametric induced modelling
approaches.
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3 The ROC-GAM regression model
As said before, the ROC-GAM regression model extends the ROC-GLM by allowing the
incorporation of arbitrary nonparametric functions for (some) continuous covariates, along
the line of the generalized additive model. Specifically, the ROC-GAM regression model is
expressed as






fk (xvk) + h0 (p)
)
, (7)
where xu and xv denote subsets of the covariate vector x. Here β0 and β are unknown
regression coefficients (modelling parametric effects of continuous covariates and, by a slight
abuse of notation, categorical covariates) and fk are unknown nonparametric functions of
continuous covariates. Under this approach, h0 is also assumed to be nonparametric (and
unknown). For identifiability reasons (see Hastie and Tibshirani 1990), a constant β0 is
introduced into the model, and it is required that E (fk (Xkv)) = 0 (k = 1, . . . , V ) and∫ 1
0
h0 (p) dp = 0.
In many situations the effect of a continuous covariate on the ROC curve may varies
across groups defined by levels of a categorical covariate. A generalization of the ‘pure’
ROC-GAM in (7) is the ROC-GAM with factor-by-curve interactions. Without loss of
generality, let us assume that X is a two-dimensional covariate, with Xv being a continuous
covariate, and Xu a factor withM levels {1, . . . ,M}. The factor-by-curve ROC-GAM takes
the form





βlI (xu = l) + f (xv) +
M∑
l=1
f l (xv) I (xu = l) + h0 (p)
)
, (8)
where β0 and {βl}
M
l=1 are unknown regression coefficients, and h0, f1 and f
l are unknown
nonparametric functions. I (A) denotes the indicator function of event A. In much the
same way as for model (7), the following conditions are required for identifiability




= 0 (l = 1, . . . ,M) and
∫ 1
0




βl = 0 and
M∑
l=1
f l (xv) = 0.
Note that, given the previous constraints, model (8) has been parametrized so it is hi-
erarchical. As a consequence, f is the smooth main effect of covariate Xv, and thus f
l
(l = 1, . . . ,M) represent deviations from that main effect for each level of Xu.
Appendix A presents the main steps of the estimation process of the ROC-GAMs (7)
and (8), and we refer the interested reader to Rodŕıguez-Álvarez et al. (2011b) for a more
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detailed description. However, for a better understanding of the procedures to be presented
in Section 4, we should note that the proposed algorithm requires the estimation of the
conditional cumulative survival function of the diagnostic test in healthy subjects, SD̄ (· | x)
(Step 2). For that purpose, Rodŕıguez-Álvarez et al. (2011b) suggest to model the effect
of covariates on YD̄ by a nonparametric location-scale regression model
YD̄ = µD̄(X) + σD̄(X)εD̄ (9)

















For ease of notation, we assume that the sets of covariates whose effects are to be modelled
parametrically and nonparametrically are the same for the conditional mean, the condi-
tional variance, and the conditional ROC curve. Obviously, this might not be necessarily
so. In addition, factor-by-curve interaction terms can also be included. Note that under
(9), it follows that






4 Testing for effects in ROC-GAM regression models
This section introduces the bootstrap-based procedures proposed to test for: (a) continuous
covariate effect on the ROC-GAM regression model specified in (7); and (b) factor-by-curve
interaction terms in model (8).
Specifically, for model (7) we focus our interest on testing for the effect of those covari-
ates modelled nonparametrically. Accordingly, for each continuous covariate Xvr in (7),
we consider the null hypothesis
Hr0 : fr(xvr) = 0.
That is to say, that the ROC curve, and therefore the accuracy of the test, is not affected
by covariate Xvr
For model (8) our interest is focused on the null hypothesis
H0 : f
1 (xv) = . . . = f
M (xv) = 0,
namely, that the effect of continuous covariate Xv on the ROC curve does not depend on
the levels of factor Xu.
In both cases, we propose the use of various tests based on the estimates of the partial
functions fr, and on the estimates of the interactions curves f
l (l = 1, . . . ,M).
From now on, let us assume that we have two independent samples of independently
and identically distributed (i.i.d.) observations (xD̄1 , y
D̄
1 ), . . . , (x
D̄
nD̄
, yD̄nD̄) from population




1 ), . . . , (x
D
nD
, yDnD) from population (XD, YD).
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4.1 Testing for continuous covariate effect
The test for the null hypothesis









fk (xvk) + h0 (p)
)
, (10)
versus the general hypothesis






fk (xvk) + h0 (p)
)
,
















Note that the proposed statistics are measures of deviations from the estimated nonpara-








which is forced to be zero during esti-
mation in order to avoid identifiability problems.
It must be remarked that, if the null hypothesis is verified, then T (T|| or T2) should be
close to zero but will be positive. Thus, for an observed value of the test statistic, T o, the
null hypothesis in (10) is rejected if the p-value P (T > T o | H0) < α, where α is a specified
level of significance.
To approximate the distributions of the test statistics under the null hypothesis a
general bootstrap procedure is proposed, which consists of the following steps:








Appendix A. Let µ̂D̄ (·), σ̂D̄ (·), and ĜD̄ (·) be these estimates.












1 ≤ j ≤ nD.
For b = 1, . . . , B






































































obtain T b (T b|| or T
b
2 ).
In Section 4.3 we proof that the resamples obtained as explained in Step 3 above verify the
null hypothesis. Accordingly, the previous procedure approximates the distribution of the
test statistic T (T|| or T2) under H0. Thus, the test rule based on T (T|| or T2) consists of
rejecting the null hypothesis if T o > TBα where T
B
α is the empirical (1-α)-percentile of the
values of T 1, . . . , TB obtained in Step 4.
4.2 Testing for factor-by-curve interaction
The test for the null hypothesis





βlI (xu = l) + f (xv) + h0 (p)
)
, (13)
versus the general hypothesis





βlI (xu = l) + f (xv) +
M∑
l=1
f l (xv) I (xu = l) + h0 (p)
)
,
is based on the estimates of the interactions curves f l (l = 1, . . . ,M). As before, L1 and




























As before, the proposed statistics are measures of deviations from the estimated nonpara-











which are forced to be zero during estimation.
The bootstrap-based testing procedure in this case is the same as that presented above
to test for the effect of continuous covariates on the ROC curve. The only difference is the
Step 2 of algorithm, which now must be








obtain the bootstrap pilot estimates R̂OC
0
xDj
(p), 1 ≤ j ≤ nD.
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4.3 Resampling under the null hypothesis
As said, a crucial point when applying the procedures presented above is to obtain boot-
strap resamples verifying the null hypothesis. In this section we show that the resampling
mechanism explained in Section 4.1 meet this requirement.












(p | x) | X = x
)
= P (SD̄ (YD | x) ≤ p | X = x) .
Thus, the conditional ROC curve may be seen as the conditional cumulative distribution
function of the random variable SD̄ (YD | x). This equivalence, in conjunction with the
location-scale regression model assumed for YD̄ (see (9)), implies that









with U ∼ U [0, 1], is a random variable with conditional cumulative survival function
S∗D (c | x) = P (Y
∗
D ≥ c | X = x)
= P
(














(SD̄ (c | x) | x) | x
)
= SD (c | x) .
Thus, given X = x, the conditional ROC curve related to YD̄ and Y
∗
D is the same as that
associated to YD̄ and YD, i.e., ROCx (·). Note that in the previous result it has been
assumed that SD̄ (· | x) is a monotonically strictly decreasing function (which also implies
that the conditional ROC curve is continuous).
Finally, it is worth emphasizing that the (conditional) ROC curve provides a description
of the separation between the (conditional) distributions of the diagnostic test in healthy
and diseased populations, regardless of the specific location of both distributions. This
property of the ROC curve, jointly with result (14), thus suggests the resampling plan
discussed in Section 4.1:
1. The healthy population is kept fixed, and a bootstrap of residuals is used to obtain
the sample in the healthy population (see eqn. (11)).
2. Result (14) is used to obtain the bootstrap sample in the diseased population, where
the theoretical quantities are replaced by their respective estimates (see eqn. (12)).
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In order to “mimic” the null hypothesis when resampling, in (14) the conditional
ROC curve under the null hypothesis (see models (10) and (13)) is put in place of
ROCx (·).
5 Simulation study
In this section we report on a simulation study designed to assess the validity of the
bootstrap-based tests described in Section 4 above. Data were simulated from three differ-
ent scenarios, namely,
Scenario I




0.2 + 0.5 exp (Xv1)εD̄,
YD = sin (πXv1) +
√
0.2 + 0.5 exp (Xv1) +
√































In all cases, a is a real constant, Xv1 was simulated from a uniform distribution on [−1, 1]
and εD̄ and εD ∼ N (0, 1). In Scenario II, Xv2 is a continuous covariate which was sim-
ulated from a uniform distribution on [−1, 1], and Scenario III represents the factor-by-
curve case. Here Xu1 ∼ Bernoulli (0.5). We note that Scenario I was also considered in
Rodŕıguez-Álvarez et al. (2011a).











































































Figure 1: For Scenario I and II: centred nonparametric function of Xv1. For Scenario
III: centred interaction curve of Xv1 for Xu1 = 1. In all cases, the partial functions are
shown for different values of a. The dotted grey line represents the null hypothesis (no















where Φ denotes the cumulative distribution function of a standard normal random vari-
able.
In order to fit a ROC-GAM regression model, several choices need to be made. In
all results shown below, the probit function, namely g−1 = Φ−1, was taken as the link
function. With respect to the set of FPFs – needed in Step 1 of the algorithm presented in
Appendix A – nP = 50 and equally spaced values were considered. We should note that
our implementation makes use of binning type acceleration techniques (Fan and Marron
1994) to reduce computational time. In this study, we used 30 equally spaced binning
points along the range of each continuous covariates. The bandwidths involved in the
local-linear kernel smoothers were selected using the standard procedure of leave-one-out
cross validation, and recomputed for each bootstrap resample.
To study the size and power of the tests, different values were considered for a, ranging
from 0 to 2. Note that a controls the deviation from the null hypothesis. In Scenarios I
and II, a = 0 corresponds to the hypothesis of no effect of covariate Xv1 on the ROC curve,
and the more the constant a shifts towards zero, the greater the effect of the covariate
on the ROC curve. For Scenario III, the value a = 0 corresponds to the hypothesis of
no interaction between Xv1 and Xu1, and as the value of a rises, so does the degree of
interaction. These behaviours are illustrated in Figure 1. Note that the y-scale is different
in the three plots. Thus, for a specific value of a (excluding a = 0), the largest deviation
from the null hypothesis would be for Scenario II and the lowest for Scenario I.
The bootstrap procedure described in Section 4.1 was applied to Scenarios I and II, and
that presented in Section 4.2 to Scenario III. In all cases, critical values and p-values were
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determined using B = 400 bootstrap samples. Both type I errors and powers were calcu-
lated as the proportion of rejections of H0 in 1000 runs, and the same sample size was con-
sidered for both healthy and diseased subjects, with n = nD = nD̄ = 50, 100, 200, 500, 1000.
For the sake of brevity, only the results for n = 50, 200, 1000 are shown below. Results for
the remaining sample sizes are in concordance with those presented here. Since p-values
should be uniformly distributed under the null hypothesis, the Kolmogorov-Smirnov (KS)
test for uniformity of the resulting p-values was also performed.
Table 1 shows the type I errors registered by the proposed tests for different significance
levels and sample sizes. The p-values of the KS-test are also shown in this table. Figure
2 depicts quantile–quantile plots of the expected p-values (under the uniform distribution)
and the observed p-values for all Scenarios and tests considered in this paper. As can be
seen, the tests performed well in general, with type I errors proving to be relatively close
to nominal errors (Table 1), and p-value distributions close to the uniform one (Figure 2).
Note that there were only two situations were the KS test rejected the null hypothesis of a
uniform distribution: for Scenario I and a sample size of n = 50, and for Scenario III and
a sample size of n = 1000. We were especially concerned about the result for Scenario III
with such a large sample size. Accordingly, we evaluated the behaviour of the tests (under
the same conditions) for a sample size of n = 2000. In this case (results not shown), the
KS test gave a p-value of 0.223 and 0.471 for S|| and S2 tests, respectively.
Power as a function of constant a and different significance levels is shown in Tables 2
and 3, and Figure 3 shows the power curves at 0.05 significance level. All tests registered
satisfactory power curves, with the probability of rejection rising in response to any increase
in the value of the constant a and the sample size. Note that the power curves also depict
the expected behaviour according to the plots shown in in Figure 1.
6 Software implementation: the npROCRegression package
This section contains a brief description of the developed R-package that
accompany this paper. The package can be freely downloaded from
https://cran.r-project.org/package=npROCRegression, where a more detailed de-
piction of it use can be found. To facilitate the use of the package by the biomedical
community, npROCRegression has been designed in a similar fashion to other regres-
sion functions/packages in R. The main functions of the package are DNPROCreg() and
INPROCReg, which estimate the conditional ROC curve based on, respectively, the nonpara-
metric direct (Rodŕıguez-Álvarez et al. 2011b) and induced (Rodŕıguez-Álvarez et al.
2011a) regression approaches. Numerical and graphical summaries of the fitted models
can be obtained by calling the functions print(), summary() and plot().
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Level
Sample size Test 0.01 0.05 0.10 0.15 0.20 KS p-value
Scenario I
50
T|| 0.011 0.070 0.126 0.173 0.220 0.020
T2 0.013 0.077 0.127 0.174 0.210 0.004
200
T|| 0.008 0.056 0.119 0.163 0.207 0.683
T2 0.011 0.057 0.109 0.161 0.204 0.939
1000
T|| 0.020 0.058 0.110 0.171 0.217 0.746
T2 0.016 0.056 0.108 0.161 0.217 0.744
Scenario II
50
T|| 0.015 0.052 0.107 0.145 0.184 0.582
T2 0.016 0.060 0.112 0.145 0.192 0.709
200
T|| 0.020 0.051 0.114 0.161 0.205 0.482
T2 0.015 0.060 0.113 0.167 0.209 0.736
1000
T|| 0.019 0.053 0.109 0.152 0.205 0.558
T2 0.019 0.055 0.111 0.168 0.203 0.657
Scenario III
50
S|| 0.015 0.053 0.097 0.143 0.191 0.412
S2 0.011 0.053 0.091 0.152 0.193 0.359
200
S|| 0.024 0.061 0.102 0.149 0.191 0.217
S2 0.021 0.061 0.102 0.148 0.192 0.170
1000
S|| 0.017 0.044 0.091 0.136 0.177 0.001
S2 0.013 0.053 0.089 0.134 0.188 0.003
Table 1: For Scenarios I, II and III: estimated type I error registered by the proposed
tests under the null hypothesis for different significance levels and sample sizes. The last
column presents the p-values of the Kolmogorov-Smirnov test for uniformity of the observed
p-values.
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Figure 2: For Scenarios I, II and III: Quantile–quantile plot for the expected p-values vs.
the observed p-values when the null hypothesis is correct.
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Level




T|| 0.023 0.068 0.133 0.184 0.227
T2 0.021 0.076 0.131 0.180 0.223
200
T|| 0.024 0.091 0.159 0.212 0.260
T2 0.024 0.077 0.145 0.211 0.265
1000
T|| 0.097 0.222 0.318 0.392 0.475
T2 0.091 0.210 0.304 0.396 0.467
a = 1.0
50
T|| 0.027 0.091 0.151 0.208 0.269
T2 0.034 0.092 0.158 0.209 0.265
200
T|| 0.070 0.169 0.251 0.339 0.403
T2 0.065 0.175 0.261 0.333 0.396
1000
T|| 0.417 0.652 0.764 0.832 0.874
T2 0.468 0.673 0.779 0.834 0.875
a = 2.0
50
T|| 0.060 0.159 0.241 0.311 0.382
T2 0.074 0.161 0.247 0.318 0.381
200
T|| 0.305 0.533 0.652 0.711 0.770
T2 0.346 0.557 0.668 0.726 0.777
1000
T|| 0.990 0.999 1.000 1.000 1.000




T|| 0.037 0.097 0.176 0.226 0.268
T2 0.032 0.097 0.164 0.225 0.280
200
T|| 0.258 0.447 0.566 0.635 0.697
T2 0.225 0.435 0.548 0.619 0.672
1000
T|| 0.993 0.996 0.998 0.998 0.999
T2 0.990 0.996 0.998 0.998 0.999
a = 1.0
50
T|| 0.142 0.305 0.398 0.473 0.540
T2 0.126 0.293 0.390 0.456 0.512
200
T|| 0.951 0.982 0.992 0.995 0.997
T2 0.928 0.979 0.985 0.993 0.995
1000
T|| 1.000 1.000 1.000 1.000 1.000
T2 1.000 1.000 1.000 1.000 1.000
a = 2.0
50
T|| 0.574 0.783 0.867 0.920 0.942
T2 0.534 0.751 0.841 0.904 0.933
200
T|| 1.000 1.000 1.000 1.000 1.000
T2 1.000 1.000 1.000 1.000 1.000
1000
T|| 1.000 1.000 1.000 1.000 1.000
T2 1.000 1.000 1.000 1.000 1.000
Table 2: For Scenarios I and II: estimated rejection probabilities registered by the proposed




Sample size Test 0.01 0.05 0.10 0.15 0.20
a = 0.5
50
S|| 0.020 0.081 0.146 0.207 0.257
S2 0.020 0.083 0.143 0.203 0.257
200
S|| 0.112 0.211 0.307 0.391 0.458
S2 0.092 0.214 0.300 0.386 0.459
1000
S|| 0.567 0.769 0.853 0.902 0.929
S2 0.527 0.753 0.848 0.890 0.917
a = 1.0
50
S|| 0.052 0.130 0.210 0.284 0.358
S2 0.050 0.127 0.208 0.276 0.347
200
S|| 0.392 0.606 0.712 0.766 0.807
S2 0.373 0.585 0.701 0.753 0.799
1000
S|| 0.998 1.000 1.000 1.000 1.000
S2 0.998 0.999 1.000 1.000 1.000
a = 2.0
50
S|| 0.111 0.270 0.372 0.464 0.527
S2 0.095 0.235 0.361 0.438 0.518
200
S|| 0.924 0.976 0.988 0.993 0.994
S2 0.894 0.969 0.986 0.991 0.992
1000
S|| 1.000 1.000 1.000 1.000 1.000
S2 1.000 1.000 1.000 1.000 1.000
Table 3: For Scenario III: estimated rejection probabilities registered by the proposed tests




























































































































































Figure 3: For Scenarios I, II and III: estimated rejection probabilities registered by the
proposed tests as a function of the parameter a, for different sample sizes and at 0.05
significance level (red line).
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6.1 DNPROCreg() function
The function DNPROCreg() estimates the conditional ROC curve in the presence of multi-
dimensional covariates by means of the ROC-GAM regression approach presented above.
Usage is as follows:







The diagnostic test variable is indicated through argument marker. The nonparamet-
ric location-scale regression model for healthy population (see (9)) is specified through
formula.h. This argument should be as a vector (of length 2) of right-hand formulas
(atomic values are also valid, being recycled). The first right-hand formula is the model for
the regression function, µD̄ (x), and the second one is the model for the (logarithm) of the
variance function, σ2
D̄
(x). These formulas are similar to that used for the glm() function,
except that nonparametric functions can be added to the additive predictor by means of
function s(). For instance, specification ∼ x1 + s(x2) would assume a linear effect of x1
and a nonparametric effect of x2. Categorical variables (factors) can be also incorporated,
as well as factor-by-curve interaction terms as discussed in Section 3. By way of example,
to include the interaction between age and gender we need to specify ∼ gender + s(age)
+ s(age, by = gender). Note that, for identifiability purposes, the “main” effects of
the continuous and categorical covariates need to be included into the formula. All these
considerations also apply to the argument formula.ROC, where the ROC-GAM regression
model (see (7) and (8)) is specified.
The name of the variable that distinguishes healthy from diseased individuals is specified
in argument group, and in tag.healthy the value codifying the healthy individuals in this
variable. The data argument is a data frame representing the data and containing all
needed variables.
Pointwise bootstrap confidence intervals for each component of the additive predictor
of the ROC-GAM, as well as the conditional AUCs (with the integral being approximated
by numerical integration methods), are obtained by setting the argument ci.fit to TRUE.
The components of the ROC-GAM to be tested for their possible effect are indicated
in test.partial. In this argument, we pass the position of the components as specified in
the formula.ROC argument.
An optional data frame containing the covariate values at which predictions are required
can be specified in argument newdata. If missing, an adequate set of points from the dataset
used in the fit is selected. To that end, the function DNPROCregdata() is used.
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Argument control allows to modify some default parameters that control the fitting
process. For instance, the cardinality of the set of FPF used in the estimation process (see
Appendix A, Step 1) can be specified using this argument (by default nP = 50), as well as
the link function or the number of bootstrap resamples and significance level used for the
construction of the confidence intervals.
6.2 INPROCreg() function
The function INPROCreg() estimates the conditional ROC curve in the presence of a one-
dimensional continuous covariate based on the induced nonparametric ROC regression
approach as presented in Rodŕıguez-Álvarez et al. (2011a). The call to the function follows:
INPROCreg (marker, covariate,
group, tag.healthy, data,
ci.fit = FALSE, test = FALSE,
accuracy = NULL, accuracy.cal = c("ROC","AROC"),
newdata = NULL, control = controlINPROCreg(),
weights = NULL)
Through marker and covariate arguments, users indicate the diagnostic test variable and
the continuous covariate of interest, respectively.
In group and tag.healthy arguments, we have to indicate respectively the name of
the variable that distinguishes healthy from diseased individuals, and the value codifying
healthy individuals in that variable. The data argument is a data frame representing the
data and containing all needed variables.
Bootstrap confidence intervals for the regression and variance functions, as well as for
several accuracy measures, are obtained by setting the argument ci.fit to TRUE. Argument
test should be set to TRUE in order to evaluate the effect of the continuous covariate on
the ROC curve by means of the test presented in Rodŕıguez-Álvarez et al. (2011a).
By default, the INPROCreg() function returns the estimated regression and variance
functions both in healthy and diseased populations. As far as accuracy measures is con-
cerned, the function provides the estimated conditional ROC curve, the associated condi-
tional AUCs (with the integral being approximated by numerical integration methods), and
the covariate-adjusted ROC curve, AROC (see (6)). In addition, it is also possible to ob-
tain the conditional Youden index (“YI”), the covariare-specific values for which the TPF
and the TNF coincide (“EQ”); and/or the covariate-specific optimal thresholds (“TH”)
based on these two criteria (argument accuracy). Both the YI and the EQ values (and
thus the optimal thresholds) can be calculated based on the conditional ROC curve or the
AROC curve (argument accuracy.cal) (see , e.g., eqn (5)). We recommend the use of the
AROC curve in those situations where the accuracy of the test does not vary along with
the covariate. We should note that, even in this case, covariate-specific thresholds will be
obtained (Rodŕıguez-Álvarez et al. 2011a).
23
An optional data frame containing the values of the covariate at which predictions are
required can be specified in argument newdata. If this dataset is not specified, an adequate
set of points from the data used in the fit is selected. A finer control of the fitting process
can be achieved by the argument control. For instance, this argument can be used to
select the number of binning points or the order of the polynomial associated to the kernel
smoothers.
7 Application to a CAD system
Computer aided diagnosis has been defined as the diagnosis made by a radiologist who
takes into account the results of quantitative computer analysis of medical diagnosis (Doi
2007). Those kind of systems have demonstrated its usefulness in situations where the
radiologists have to discriminate positive cases among hundreds or thousands of normal
cases. Those screening programs suppose a challenge for the physicians and the presence of
a second reader in form of computer algorithm has demonstrated to be useful (Nishikawa
2007). The base of a CAD system is a computer vision algorithm where several parameters
extracted from some features particularly selected from the image, are combined by means
of a classifier specially trained for discriminating between normal and abnormal cases.
CAD schemes have been developed for screening programs related to breast, chest, colon,
etc.
Quality in terms of image can be described in terms of three basic concepts: contrast,
spatial resolution and noise. For x–ray images the subjective contrast (the contrast mea-
sured before the capture of the image by the recording system) is modelled by three main
factors: the energy of the photons that constitute the x–ray beam, the thickness of the
object to visualize and the linear attenuation coefficient of the material that compose the
object, which is related with its density.
The breast is mainly made up of fat and glandular tissue. The attenuation coefficient
of fat and glandular tissue is quite different, having glandular tissue a higher attenuation
coefficient. To achieve mammographies of good quality in terms of contrast, the whole
breast is physically compressed, and x–ray photons of low energy are employed. But still,
the volume of the breast and its composition differ from breast to breast. Thus, the
contrast and even the average grey level (AGL) of the pixels of the final image could be
quite different, despite the use of automatic exposure control systems for image acquisition.
The consequence is that for humans and machines, the task of detection of possible cancers,
become more difficult.
For breast cancer detection, the identification of masses and microcalcifications consti-
tutes the main issue. Microcalcifications are small radiopacities of high contrast, whereas
masses are radiopacities of median size and low contrast. The main problem for mass
detection is the presence of several structures related with glandular tissue that has similar
attenuation coefficient as masses. In some cases the presence of such structures is massive
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(dense breast) hiding the presence of masses. By the contrary, when the presence of glan-
dular tissue is negligible, masses are clearly visualize from the background compose mainly
of fat and its detection become relatively easy.
One important issue in the development of a CAD scheme is to analyse the impact
that a particular variable has over the performance of the whole system. For breast cancer
detection, its behaviour with respect to the presence of glandular tissue is also an essential
aspect. To this aim, in this paper we have analysed this effect over a CAD scheme for breast
masses detection previously developed (see Varela et al. 2007; for a detailed description).
The system is based on the extraction of several image features that can be grouped into
three main categories: contour related, texture and tone. Among the texture features, the
variables related with the iris filter have a special importance in terms of the performance
of the system. The iris filter is an algorithm specially designed to enhance round brilliant
structures within an image. Since a mass has this appearance in a mammogram, the
variables related with that feature are of special interest.
7.1 Data set
The database contain 580 mammograms where a total of 190 images were classified as
abnormal (lesion present), and the remaining 390 as normal images (no lesion present).
From the 580 original mammograms, a total of 2796 regions suspicious of being a malignant
mass were detected by the computer in a first step. Of these, 384 corresponded to true
masses, and the remainder, a total of 2412, corresponded to false detections.
7.2 Data analysis
One of the main purposes of this study on CAD systems was to assess the effects of some
covariates as the average grey level (AGL) of the pixels forming the suspicious region and
the breast tissue type (TIS) on the accuracy of the iris filter (IRIS) when discriminating
between real malignant masses (D) and false detections (D̄). To evaluate such effects,
Rodŕıguez-Álvarez et al. (2011b) suggested the use of (semi) parametric ROC regression
techniques combined with B-splines, to model the nonlinear effect of AGL on the iris filter,
which in turn may vary among tissue types. In this section we re-analyse the CAD data,
now using the fully nonparametric ROC-GAM regression approach described in Section 3.
This approach allows for the nonparametric specification of the effect of AGL on the ROC
curve. Also, the bootstrap-based tests suggested in Section 4 are used to check formally the
possible effects on the ROC curve of the covariate AGL and the tissue-by-AGL interaction.
As a first step of the analysis, the discriminatory capacity of the iris filter was evaluated
without taking into account the effect of the covariates. The AUC value corresponding to
the pooled ROC curve was 0.69. ROC analysis was also performed for dense and fatty
tissues separately, yielding pooled AUCs of 0.64 and 0.75, respectively. Additionally, we
also estimated the AGL-adjusted ROC curves (AROC), both for dense and fatty tissues.
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The areas under these AROC curves, were in this case 0.60 and 0.73. Note that they
are slightly lower than the pooled AUCs, possibly indicating that the pooled analyses
‘incorporates’ the portion of discrimination attributable to AGL (Pardo-Fernández et al.
2014). In any case, these results suggest that the discriminatory capacity of the iris filter
is larger for fatty than for dense tissue.
In order to explore the possible effect of the continuous covariate AGL on the iris
filter (and thus on its accuracy), we first considered the induced ROC regression method-
ology discussed in Section 2.1.1. Specifically, the following nonparametric location-scale
regression models were assumed for false detection and true masses (separate analyses were
conducted on dense and fatty tissues)
IRISD̄= µD̄(AGL) + σD̄(AGL)εD̄,
IRISD= µD(AGL) + σD(AGL)εD,
(15)
Figure 4 depicts the estimated effect of AGL both on the mean and standard deviation of
filter output, according to breast tissue type, along with 95% pointwise confidence intervals.
For masses, in both fatty and dense tissues, mean values rise to a peak approximately
midway through the interval and fall thereafter. As a feature that measures the gradual
variation in the region’s grey level value, filter output tends to rise to a maximum in these
intermediate areas, since it is here that such variation could register its most extreme values.
For false detections, the pattern is more homogeneous, owing to the fact that, ideally, grey
level values display no gradual variation and are instead homogeneously distributed.
The results shown in Figure 4 provide very useful information. First, they suggest the
presence of nonlinear effects of AGL on IRIS, which we may expect to find on its diagnostic
accuracy. Second, discrimination based on iris output is much more complex in dense than
in fatty tissue. For dense tissue, mean iris filter values are quite similar both for true
masses and false detections, and this behaviour is shared by all AGL values. Finally, these
results also seem to indicate the existence of a possible interaction between average grey







βlI (TIS = l) + f(AGL) +
2∑
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Here TIS is a binary variable taking a value of 1 in the case of dense tissue and 2 in the
case of fatty.
Figure 5 shows the estimated partial functions f (global effect of AGL), f1 (deviation
for dense tissue) and f2 (deviation for fatty tissue), together with the corresponding 95%
pointwise bootstrap confidence intervals. In Figure 6 the estimated conditional AUCs
based on model (16) are shown. We would like to point out that, the estimated AUCs
obtained using the induced approach were quite similar to those depicted in Figure 6. For
clarity in the presentation, these AUC estimates are not shown. As can be seen in Figure 6,
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Figure 4: Nonparametric estimates of IRIS by AGL in dense and fatty tissue populations,
along with 95% pointwise bootstrap confidence intervals. Solid line: true masses. Dashed
line: false detection. Left: nonparametric mean functions. Right: nonparametric variance
functions.
27

























































Figure 5: Estimated main effect of AGL in IRIS’s accuracy, and deviation for dense and
fatty tissue, together with 95% pointwise bootstrap confidence intervals.




































Figure 6: Estimated conditional AUC for the CAD system according to AGL and type of
tissue. The dashed lines represent the 95% pointwise bootstrap confidence intervals.
the behaviour of the iris filter achieves better results for fatty breasts as we might expect.
Moreover its performance drops as the AGL increases. This is consistent with the fact
that in average, pixel values for fatty breast are relatively low. When the average pixel
value rises it is probably because the overall contrast of the whole breast decreases, due to
size of the breast, the energy of the x–ray beam or both. In any case, the quality of the
image get worse, and the results achieved by the filter are not as good. By the contrary,
for dense breast, results are almost similar along the range of the pixel values. In this case,
the presence of structures related with the glandular tissue makes the iris filter do not
works properly and as a consequence the enhancement of the mass with respect to other
structures is not as pronounced, degrading the detection capabilities of the whole system.
All the previous results suggest that the presence of interaction between the type of
tissue and the average grey levels might be plausible. For the purpose of statistically
28
verifying this hypothesis, we performed the tests presented in Section 4.2. The resulting p-
values were 0.02 and 0.10 for S|| and S2 respectively. Assuming a significance level of 0.05,
the result based on S2 does not suggest the presence of interaction. However, the p-value
obtained with S|| was lower than 0.05, thus rendering the interaction term significant.
Although the results of both tests could lead to different conclusions, based on all
results presented we are prone to accept the presence of interaction. However, note that a
significant interaction does not say anything about the effect of AGV on the accuracy of
IRIS: it solely indicates that this effect is different in dense and fatty tissues. Thus, the
last step in our analyses was to check for the effect of AGL on the accuracy of IRIS. To
that aim, the following ROC-GAM model was fitted separately in fatty and dense tissues
ROCAGL(p) = g (β0 + f(AGL) + h0(p)) ,
and we performed the tests for continuous covariate effects outlined in Section 4.1 above.
Whereas the p-value obtained in the case of dense tissue was 0.54, in the case of fatty tissue
was < 0.001. So we can conclude that the accuracy of IRIS is constant along AGL in the
dense tissue while in fatty tissue population the accuracy of IRIS depends significantly on
AGL.
7.3 Source code
The R-code used to fit the models presented in Section 7.2 above is now given. For the
nonparametric induced approach presented in (15), the following code was used
library(npROCRegression)
# Set several parameters controlling the fitting process
# p: order of the local polynomial kernel smoother to be used
# for estimating the conditional mean functions.
# kbin: number of binning points to be used for the binning
# approximation.
control.ind = controlINPROCreg(p = 1, kbin = 50)
# Dense tissue
mod.dense <- INPROCreg(marker = "IRIS", covariate = "AGL",
group = "MASS", tag.healthy = 0,
data = subset(masses, TIS == "Dense"),
ci.fit = TRUE, test = TRUE, control = control.ind)
# Fatty tissue
mod.fatty <- marker = "IRIS", covariate = "AGL",
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group = "MASS", tag.healthy = 0,
data = subset(masses, TIS == "Fatty"),
ci.fit = TRUE, test = TRUE, control = control.ind)
Regarding the ROC-GAM model including the AGL-by-tissue interaction, model (16), the
R-code is listed bellow
# card.P: cardinality of the set of FPF to be used for estimating
# the ROC-GAM model.
# kbin: number of binning points to be used for the binning
# approximation.
control.d = controlDNPROCreg(card.P = 50, kbin = 50)
# Fit the model
mod.int <- DNPROCreg(marker = "IRIS",
formula.h = ∼ TIS + s(AGL) + s(AGL, by = TIS),
formula.ROC = ∼ TIS + s(AGL) + s(AGL, by = TIS),
group = "MASS", tag.healthy = 0,
data = masses, control = control.d,
ci.fit = TRUE, test.partial = 3)
Note that we include the interaction between AGL and TIS not only in the ROC-GAM
(formula.ROC), but also in the nonparametric location-scale regression model assumed
for healthy population (see (9)), in both the conditional mean and the logarithm of the
conditional variance (formula.h). Also, by specifying test.partial = 3 we test for the
interaction, which is modelled by means of the third component of the ROC-GAM formula,
i.e., s(AGL, by = TIS).
8 Discussion
This paper proposes and investigates test statistics to evaluate effects of continuous co-
variate and factor-by-curve interactions in a ROC-GAM regression model. The practical
implementation of the proposed tests relies on approximating their distribution under the
null hypotheses by means of bootstrap techniques. To that aim, a resampling mechanism
that obeys the null hypothesis is proposed. Simulation results show that the proposed
procedures yield type I errors relatively close to nominal errors, regardless of sample size.
As expected, the power grows as sample size increases and as one moves further away from
the null hypothesis. The behaviour of the tests can be considered satisfactory.
Our calculations were done with the R-package npROCRegression that can be
freely downloaded from https://cran.r-project.org/package=npROCRegression.
The R-code used for the simulations can also be found in
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https://bitbucket.org/mxrodriguez/rocgam inference. The package covers a vari-
ety of nonparametric regression approaches for the inclusion of covariate information
on the ROC curve. However, it would be worthwhile to include some extensions of
interest. For instance, it could be useful to extend the package, and more precisely the
ROC-GAM approach implementation, to allow for the presence of two or more diagnostic
tests, and to provide inferential procedures for comparing the accuracy of these tests.
Also, the incorporation of additional optimal threshold criteria may constitute another
important issue to cover in the future (López-Ratón et al. 2014). Currently, estimates of
the conditional AUC and Youden Index (and associated threshold values) are obtained by
simply plugging-in an estimate for the conditional ROC curve in (3) and (5), respectively.
Further work is warranted to implement direct estimators, such as those presented in
Yao et al. (2010) and Xu et al. (2014).
The methods presented in this paper also ask for further research efforts. On the one
hand, the parametrization used for the factor-by-curve interaction model allows evaluating
the presence of such interaction component. If the result of the tests bring to reject the
absence of interaction, it would be of great interest to study in which groups defined by
the categorical covariate, the continuous covariate has an impact on the accuracy of the
diagnostic test. In the data analyses presented in this paper, this question is answered by
fitting a separate ROC-GAM model in fatty and dense tissue. We are currently working
on alternative parametrizations that would permit to find out which groups present a
significant continuous covariate effect, but without the need to fit separate models. On
the other hand, this paper focuses on testing for effects modelled by means of univariate
nonparametric functions. The extension of both the estimation algorithm and the testing
procedures to bivariate nonparametric functions (curve-by-curve interactions) represents
an interesting line of research. Note that these extensions would allow incorporating (and
testing) the interaction between continuous covariates and the FPF. However, as pointed
out before, estimation in this case should ensure monotonicity in the FPF direction.
Concerning the application of the results of this paper to the development of CAD
systems, the possibility of analysing and evaluating covariate effects can help in the de-
velopment of new algorithms of image feature extraction. Furthermore, the possibility of
introducing a more deeper analysis of side effects in the behaviour of the algorithm, such as
the interactions between covariates or the introduction of a factor, open the possibility to
propose design alternatives that would allow to create more complex and useful algorithms.
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A ROC-GAM estimation procedure
This appendix describes the estimation process associated to the ROC-GAM regres-
sion models (7) and (8). We present here the main steps of the algorithm, and re-
fer the reader to Rodŕıguez-Álvarez et al. (2011b) for more details. More precisely, in
Rodŕıguez-Álvarez et al. (2011b) the algorithm proposed by Alonzo and Pepe (2002) for
the estimation of ROC-GLMs was extended to allow for nonparametric covariate effects.
The steps of proposed procedure can be summarized as follows
Step 1. Choose a set of FPFs P = {pl}
nP
l=1 ⊂ (0, 1) where the conditional ROC curve will
be evaluated;








Step 3. For each observation in the diseased population, calculate the estimated ‘place-






, 1 ≤ j ≤ nD;
Step 4. For each pl ∈ P and each disease observation, calculate the binary placement










, 1 ≤ l ≤ nP , 1 ≤ j ≤ nD; and





, l = 1, . . . , nP , j = 1, . . . , nD
}
and obtain the estimates
R̂OCx (p).
Note that in Step 5 above the binary indicators, B̂jpl , are the response variable.
This suggests the use of GAM estimation techniques for binary response data. In
Rodŕıguez-Álvarez et al. (2011b) it is proposed the use of the local scoring estimation
algorithm with backfitting (Hastie and Tibshirani 1990), and estimates of fk, f
l and h0
are obtained by applying local polynomial kernel smoothers (Fan and Gijbels 1996). In
the present paper, both for the simulations and the real data analyses, we used local-
linear smoothers jointly with binning-type acceleration techniques to speed up computa-
tion (Fan and Marron 1994). The optimal bandwidths were selected by means of cross
validation.
As far as model (9) is concerned (involved in Step 2), nonparametric estimates of µD̄ (·)
and σD̄ (·), say µ̂D̄ (·) and σ̂D̄ (·), are obtained by means of local-linear kernel smoothers and
the backfitting algorithm, and the cumulative survival function of the regression error GD̄
is estimated by the corresponding empirical cumulative survival function of the estimated



















i = 1, . . . , nD̄ (see Rodŕıguez-Álvarez et al. 2011b; for more details).
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